Cholesterol Lowering in the Management of Coronary Artery Disease: The Clinical Implications of Recent Trials
- 1 February 1998
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 104 (2) , 2S-5S
- https://doi.org/10.1016/s0002-9343(98)00038-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Benefits and Risks of HMG-CoA Reductase Inhibitors in the Prevention of Coronary Heart Disease A ReappraisalDrug Safety, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993
- Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.Circulation, 1993
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984